TY - JOUR
T1 - A Cluster Sequencing Strategy To Determine the Consensus Affinity Domains in Heparin for Its Binding to Specific Proteins
AU - Shi, Deling
AU - Sheng, Anran
AU - Bu, Changkai
AU - An, Zizhe
AU - Cui, Xueying
AU - Sun, Xiaojun
AU - Li, Hongmei
AU - Zhang, Fuming
AU - Linhardt, Robert J.
AU - Zhang, Tianji
AU - Jin, Lan
AU - Chi, Lianli
N1 - Publisher Copyright:
© 2022 American Chemical Society.
PY - 2022/10/11
Y1 - 2022/10/11
N2 - Glycosaminoglycans (GAGs) have high negative charge and are biologically and pharmaceutically important because their high charge promotes a strong interaction with many proteins. Due to the inherent heterogeneity of GAGs, multiple oligosaccharides, containing certain common domains, often can interact with clusters of basic amino acid residues on a target protein. The specificity of many GAG-protein interactions remains undiscovered since there is insufficient structural information on the interacting GAGs. Herein, we establish a cluster sequencing strategy to simultaneously deduce all major sequences of the affinity GAG oligosaccharides, leading to a definition of the consensus sequence they share that corresponds to the specific binding domain for the target protein. As a proof of concept, antithrombin III-binding oligosaccharides were examined, resulting in a heptasaccharide domain containing the well-established anticoagulant pentasaccharide sequence. Repeating this approach, a new pentasaccharide domain was discovered corresponding to the heparin motif responsible for binding interferon-γ(IFNγ). Our strategy is fundamentally important for the discovery of saccharide sequences needed in the development of novel GAG-based therapeutics.
AB - Glycosaminoglycans (GAGs) have high negative charge and are biologically and pharmaceutically important because their high charge promotes a strong interaction with many proteins. Due to the inherent heterogeneity of GAGs, multiple oligosaccharides, containing certain common domains, often can interact with clusters of basic amino acid residues on a target protein. The specificity of many GAG-protein interactions remains undiscovered since there is insufficient structural information on the interacting GAGs. Herein, we establish a cluster sequencing strategy to simultaneously deduce all major sequences of the affinity GAG oligosaccharides, leading to a definition of the consensus sequence they share that corresponds to the specific binding domain for the target protein. As a proof of concept, antithrombin III-binding oligosaccharides were examined, resulting in a heptasaccharide domain containing the well-established anticoagulant pentasaccharide sequence. Repeating this approach, a new pentasaccharide domain was discovered corresponding to the heparin motif responsible for binding interferon-γ(IFNγ). Our strategy is fundamentally important for the discovery of saccharide sequences needed in the development of novel GAG-based therapeutics.
UR - http://www.scopus.com/inward/record.url?scp=85139395619&partnerID=8YFLogxK
U2 - 10.1021/acs.analchem.2c03267
DO - 10.1021/acs.analchem.2c03267
M3 - Article
AN - SCOPUS:85139395619
SN - 0003-2700
VL - 94
SP - 13987
EP - 13994
JO - Analytical Chemistry
JF - Analytical Chemistry
IS - 40
ER -